AptarGroup, Inc. ATR
144.12 USD -0.01 (-0.01%)
At closeNov 10, 2026, 4:05 PM EST
144.12 0.00 0.00%
After hours · Nov 10, 4:05 PM ET
141.48 Day range 145.22
111.94 52-week range 146.86
- YTD
- +18.17%
- 1 year
- +23.84%
News
prnewswire.com SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of AptarGroup, Inc. (NYSE: ATR) NEW YORK, Nov. 10, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating AptarGroup, Inc. (NYSE: ATR) on behalf of the company's shareholders. The investigation seeks to…
seekingalpha.com Dividend Champion, Contender, And Challenger Highlights: Week of November 8 A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
globenewswire.com Rakovina Therapeutics to Present Brain-Penetrant ATR Inhibitor Data at the 31st Society for Neuro-Oncology Annual Meeting Poster to highlight AI-designed kt-5000AI compounds developed for PTEN-deficient brain tumours Poster to highlight AI-designed kt-5000AI compounds developed for PTEN-deficient brain tumours
seekingalpha.com Dividend Announcements: October 24-30, 2026 (Part 1 Of 2) I monitor dividend increases and cuts across 1,200+ stocks, focusing on dividend growth streaks, safety, and valuation to identify conviction opportunities. V, APH, and HIG stand out for robust…
zacks.com Investing in AptarGroup (ATR)? Don't Miss Assessing Its International Revenue Trends Examine AptarGroup's (ATR) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
prnewswire.com Atrium Therapeutics to Present Nonclinical Data Showing ATR 1072 Reversed and Improved Features of PRKAG2 Syndrome During HCMS at AHA Scientific Sessions 2026 -- ATR 1072 impacted key characteristics of PRKAG2 syndrome, including accumulation ofcardiac glycogen and cardiac hypertrophy -- -- Data further reinforce scientific rationale for ATR 1072 targeting…
fool.com Aptar: 3 Key Takeaways for Long-Term Investors Beauty sales surged 8% but margins stumbled in North America, exposing an execution gap management must close.
seekingalpha.com Emerson Among 14 Dividend Growth Companies To Announce Annual Dividend Increases In First Half Of November Emerson is set to extend its dividend growth streak to 70 years, with a predicted 6.3–8.1% increase driven by a business transformation. EMR's shift to higher-margin Intelligent Devices and Software…
seekingalpha.com Dividend Champion, Contender, And Challenger Highlights: Week November 1 A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies that changed their dividends. Companies with upcoming ex-dividend dates.
seekingalpha.com AptarGroup, Inc. (ATR) Q3 2026 Earnings Call Transcript AptarGroup, Inc. ( ATR ) Q3 2026 Earnings Call October 30, 2026 9:00 AM EDT Company Participants Marry Skafidas - Senior Vice President of Investor Relations & Communications Gael Touya - CEO,…
marketbeat.com What AptarGroup (ATR) Said on Its Q3 Earnings Call AptarGroup NYSE: ATR reported third-quarter 2026 sales growth across its three business segments, while adjusted profitability declined from the prior year as emergency medicine destocking and lower…
benzinga.com AptarGroup Q3 2026 Earnings Call Transcript AptarGroup (NYSE:ATR) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
zacks.com AptarGroup (ATR) Q3 Earnings and Revenues Beat Estimates AptarGroup (ATR) came out with quarterly earnings of $1.52 per share, beating the Zacks Consensus Estimate of $1.46 per share. This compares to earnings of $1.62 per share a year ago.
benzinga.com AptarGroup Raises Quarterly Cash Dividend From $0.48 To $0.50 Per Share AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its Board of Directors declared a quarterly…
businesswire.com Aptar Reports Third Quarter 2026 Results CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Third Quarter 2026 Results.
businesswire.com Aptar Increases Quarterly Dividend to $0.50 Per Share CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Increases Quarterly Dividend to $0.50 Per Share.
globenewswire.com Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program EMphora™ platform integrates clinical evidence and predictive modelling to help identify promising cancer patient populations and guide the next phase of research EMphora™ platform integrates…
benzinga.com AptarGroup's Pharma Unit Partners With Stevanato Group To Provide System-Level Data Supporting Earlier Evaluation Of Pre-Filled Syringe Configurations Focus in on sensitive biologics and other injectable therapies. The work builds on Aptar Pharma's integrated system-level framework, launched in July 2026, and brings complementary expertise together…- benzinga.com AptarGroup To Acquire PULMOTREE, A Munich, Germany-based Life Science Company Specializing In Pulmonary Drug Delivery Systems For Targeted Delivery To The Lungs; Terms Not Disclosed Acquisition is expected to accelerate development and commercialization of Kolibri™ and expand Aptar Pharma’s respiratory drug delivery platformAptar Pharma, a global leader in drug delivery, dosing,…
defenseworld.net AptarGroup, Inc. $ATR Stock Bought by State of Alaska Department of Revenue State of Alaska Department of Revenue raised its holdings in AptarGroup, Inc. (NYSE: ATR) by 53.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange…
defenseworld.net AptarGroup, Inc. (ATR) – What Are Brokerages Saying About This Stock? Shares of AptarGroup, Inc. (NYSE: ATR - Get Free Report) have been given a consensus rating of "Moderate Buy" by the ten ratings firms that are currently covering the firm, MarketBeat.com reports.…
benzinga.com AptarGroup's Aptar Pharma Reveals CE Marking For LuerVax Aptar Pharma, part of AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its LuerVax® intranasal…
benzinga.com UBS Initiates Coverage On AptarGroup with Neutral Rating, Announces Price Target of $135 UBS analyst Anojja Shah initiates coverage on AptarGroup (NYSE:ATR) with a Neutral rating and announces Price Target of $135.
zacks.com AptarGroup (ATR) Loses 5.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner AptarGroup (ATR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings…
zacks.com 3 Packaging Stocks Worth Watching Despite Industry Pressure Although weak demand and tariffs cloud the Zacks Containers - Paper and Packaging industry's near-term outlook, AVY, ATR and KRT are navigating the challenges well.
benzinga.com AptarGroup’s Russian Subsidiary Placed Under Temporary External Administration By Kremlin Decree; Says Aptar Vladimir Represented Less Than 0.6% Of Net Sales And Operating Income As Of Dec 31, 2025 AptarGroup, Inc. (the "Company") takes note of the decree of the President of the Russian Federation, published on September 21, 2026, that places the Company’s Russian subsidiary, OOO Aptar Vladimir…
defenseworld.net AptarGroup, Inc. $ATR Shares Sold by Tidal Investments LLC Tidal Investments LLC lowered its position in AptarGroup, Inc. (NYSE: ATR) by 24.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.…- benzinga.com Aptar Collaborates With Massachusetts General Hospital To Advance Nose-To-Brain Drug Delivery And Accelerate CNS Pipelines Goal is to help pharmaceutical innovators evaluate opportunities earlier and accelerate future central nervous system pipelinesAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing…
benzinga.com Wells Fargo Maintains Overweight on AptarGroup, Raises Price Target to $155 Wells Fargo analyst Gabe Hajde maintains AptarGroup (NYSE:ATR) with a Overweight and raises the price target from $145 to $155.
benzinga.com AptarGroup Q2 Adj. EPS $1.42 Beats $1.35 Estimate, Sales $1.027B Beat $1.008B Estimate AptarGroup (NYSE:ATR) reported quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.35 by 5.19 percent. This is a 14.46 percent decrease over earnings of $1.66 per…
benzinga.com Earnings Scheduled For April 30, 2026 
benzinga.com AptarGroup Hires New CEO AptarGroup names Gael Touya CEO, signaling continuity as analysts react and stock shows mixed momentum near key levels.
benzinga.com Top 2 Energy Stocks That May Plunge This Quarter Momentum stocks in the energy sector are currently flashing a warning for investors. The RSI indicator shows overbought conditions for NAT and TEN.
benzinga.com Top 2 Defensive Stocks That May Implode This Month 
benzinga.com Top 2 Consumer Stocks You May Want To Dump This Quarter 
benzinga.com Top 2 Utilities Stocks That May Collapse This Month 
benzinga.com Top 3 Materials Stocks That May Plunge This Month - benzinga.com Earnings Scheduled For February 5, 2026
- benzinga.com AptarGroup Announces That Its Bidose Liquid Nasal Spray System Liquid Is The Mechanism For Delivering The Newly Approved CARDAMYST Aptar Group, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that its Bidose (BDS) Liquid Nasal Spray System is the…
benzinga.com Earnings Scheduled For October 30, 2025 
benzinga.com Earnings Scheduled For July 31, 2025 - benzinga.com Earnings Scheduled For May 1, 2025
benzinga.com Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday? Wall Street slumped into negative territory late in the week as renewed fears over inflation and trade tariffs eroded risk appetite.
benzinga.com Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday? It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged…- benzinga.com Earnings Scheduled For February 6, 2025
- benzinga.com Earnings Scheduled For February 8, 2024 Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
- benzinga.com Earnings Scheduled For October 25, 2023 Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion.
- benzinga.com Top 3 Materials Stocks That May Implode This Month The most overbought stocks in the materials sector presents an opportunity to go short on these overvalued companies.
- benzinga.com Earnings Scheduled For July 27, 2023 Companies Reporting Before The Bell • SES AI (NYSE:SES) is projected to report quarterly earnings at $0.11 per share on revenue of $337.60 million.
- benzinga.com Earnings Scheduled For April 27, 2023 Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its first quarter.